Clinical Trial Update: Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 trial comparing radiotherapy plus panitumumab versus chemoradiotherapy in unresected, locally advanced head and neck squamous cell carcinoma; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Cancer, Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-23